Literature DB >> 11064823

Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.

A R Bradwell1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064823     DOI: 10.1385/CRIAI:19:1:19

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


× No keyword cloud information.
  8 in total

1.  Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

Authors:  F Graus; J Dalmou; R Reñé; M Tora; N Malats; J J Verschuuren; F Cardenal; N Viñolas; J Garcia del Muro; C Vadell; W P Mason; R Rosell; J B Posner; F X Real
Journal:  J Clin Oncol       Date:  1997-08       Impact factor: 44.544

2.  Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy.

Authors:  P C Wilkinson; J Zeromski
Journal:  Brain       Date:  1965-09       Impact factor: 13.501

Review 3.  Clinical enigmas of paraneoplastic neurologic disorders.

Authors:  J B Posner; J Dalmau
Journal:  Clin Neurol Neurosurg       Date:  1995-02       Impact factor: 1.876

Review 4.  Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature.

Authors:  V A Lennon
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

Review 5.  Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity.

Authors:  J Dalmau; J B Posner
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

6.  The case for a descriptive generic nomenclature: clarification of immunostaining criteria for PCA-1, ANNA-1, and ANNA-2 autoantibodies.

Authors:  V A Lennon
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

Review 7.  Paraneoplastic neurologic syndromes.

Authors:  R C Hinton
Journal:  Hematol Oncol Clin North Am       Date:  1996-08       Impact factor: 3.722

Review 8.  Immune diagnosis of paraneoplastic neurological disease.

Authors:  J W Moll; C J Vecht
Journal:  Clin Neurol Neurosurg       Date:  1995-02       Impact factor: 1.876

  8 in total
  1 in total

Review 1.  Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies.

Authors:  Zhiwei Fang; Yunqi Yang; Xuan Chen; Weiwang Zhang; Yangmei Xie; Yinghui Chen; Zhenguo Liu; Weien Yuan
Journal:  Front Immunol       Date:  2017-04-25       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.